$17.92
1.156.86%
마지막 업데이트: Oct 20, 7:54 PM
$18.01
1.247.39%
Benzinga
Benzinga
Benzinga
수요일, 10월 21
Benzinga
© 2026 Benzinga | All Rights Reserved
Immunome (IMNM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.51 | $-0.56 | $-0.60 | $-0.55 |
| Actual | $-0.65 | $-0.48 | $-0.75 | $-0.65 |
| Surprise | -27.5% | +14.3% | -25.0% | -18.2% |
| Revenue | ||||
| Estimate | $533336 | $533336 | $784620 | $727270 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.61 | $-0.62 | $-0.69 | $-0.72 |
| Revenue | ||||
| Consensus | $506664 | $506664 | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.65 | $-0.51 | -27.5 % |
| Q1 | May 12, 2026 | $-0.48 | $-0.56 | 14.3 % |
| Q4 | Mar 3, 2026 | $-0.75 | $-0.60 | -25.0 % |
| Q3 | Nov 6, 2025 | $-0.65 | $-0.55 | -18.2 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $0 | $533.34K | -100.0 % |
| Q1 | May 12, 2026 | $0 | $533.34K | -100.0 % |
| Q4 | Mar 3, 2026 | $0 | $784.62K | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $727.27K | -100.0 % |